abstract |
The invention relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof: where m, p, A, Ar, Ar, Ar, R, R and R are as defined in the specification. The compounds of formula (I) can be used as antagonists of the peptide associated with the calcitonin gene (CGRP), and can be used for treatment. |